rPA vaccine containing alhydrogel

BIOLOGICAL2 trials

Sponsors

PharmAthene UK Limited

Conditions

Bacillus Anthracis (Anthrax)Prevention of Bacillus Anthracis (Anthrax) Infection

Phase 2

Phase II Study of Range and Schedule of rPA Doses

CompletedNCT00170456

PharmAthene UK LimitedPrevention of Bacillus Anthracis (Anthrax) Infection

Start: 2005-03-31End: 2007-02-28Updated: 2008-09-15

Safety, Tolerability and Immunogenicity of Recombinant Anthrax Vaccine Compared With Anthrax Vaccine Adsorbed

CompletedNCT00170469

PharmAthene UK LimitedBacillus Anthracis (Anthrax)

Start: 2005-03-31End: 2007-02-28Updated: 2008-09-15